Dynamic visualization of dendritic cell-antigen interactions in the skin following transcutaneous immunization

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Rattanapak, Teerawan ^a   Birchall, James C ^b   Young, Katherine ^a   Kubo, Atsuko ^c   Fujimori, Sayumi ^c   Ishii, Masaru ^c   Hook, Sarah ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIGEN; VACCINE; ANTIGEN; BACTERIAL PROTEIN; OVALBUMIN; PEPTIDE FRAGMENT; PHOTOPROTEIN; YELLOW FLUORESCENT PROTEIN, BACTERIA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELL INTERACTION; COLLOID; CONTROLLED STUDY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TRANSPORT; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNIZATION; LANGERHANS CELL; MALE; MICRONEEDLE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; STRATUM CORNEUM; TRANSCUTANEOUS IMMUNIZATION; VACCINE PRODUCTION; ANIMAL; C57BL MOUSE; CELL COMMUNICATION; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; MULTIPHOTON MICROSCOPY; SKIN;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS; BACTERIAL PROTEINS; CELL COMMUNICATION; DENDRITIC CELLS; FEMALE; IMMUNIZATION; LANGERHANS CELLS; LUMINESCENT PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE, MULTIPHOTON; OVALBUMIN; PEPTIDE FRAGMENTS; SKIN;

EID: 84896065891     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089503     Document Type: Article

References (67)

1. Merad M, Ginhoux F, Collin M (2008) Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunology 8: 935-947.
2. Romani N, Clausen BE, Stoitzner P (2010) Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev 234: 120-141.
3. Dupasquier M, Stoitzner P, van Oudenaren A, Romani N, Leenen PJM (2004) Macrophages and Dendritic Cells Constitute a Major Subpopulation of Cells in the Mouse Dermis. J Investig Dermatol 123: 876-879. (Pubitemid 39391932)
4. Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, et al. (2000) Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12: 71-81. (Pubitemid 30069216)
5. Poulin LF, Henri S, de Bovis B, Devilard E, Kissenpfennig A, et al. (2007) The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med 204: 3119-3131.
6. Igyártó Botond Z, Haley K, Ortner D, Bobr A, Gerami-Nejad M, et al. (2011) Skin-Resident Murine Dendritic Cell Subsets Promote Distinct and Opposing Antigen-Specific T Helper Cell Responses. Immunity 35: 260-272.
7. Henri S, Poulin LF, Tamoutounour S, Ardouin L, Guilliams M, et al. (2010) CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J Exp Med 207: 189-206.
8. Elnekave M, Furmanov K, Nudel I, Arizon M, Clausen BE, et al. (2010) Directly Transfected Langerin+ Dermal Dendritic Cells Potentiate CD8+ T Cell Responses following Intradermal Plasmid DNA Immunization. J Immunol 185: 3463-3471.
9. Stoecklinger A, Eticha TD, Mesdaghi M, Kissenpfennig A, Malissen B, et al. (2011) Langerin + Dermal Dendritic Cells Are Critical for CD8+ T Cell Activation and IgH γ-1 Class Switching in Response to Gene Gun Vaccines. J Immunol 186: 1377-1383.
10. Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, Ponec M (2003) Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 42: 1-36. (Pubitemid 35418207)
11. Rattanapak T, Young K, Rades T, Hook S (2012) Comparative study of liposomes, transfersomes, ethosomes and cubosomes for transcutaneous immunisation: characterisation and in vitro skin penetration. J Pharm Pharmacol 64: 1560-1569.
12. Rizwan SB, Hanley T, Boyd BJ, Rades T, Hook S (2009) Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics. J Pharm Sci 98: 4191-4204.
13. Norlen L, Al-Amoudi A (2004) Stratum Corneum Keratin Structure, Function, and Formation: The Cubic Rod-Packing and Membrane Templating Model. J Investig Dermatol 123: 715-732. (Pubitemid 39281613)
14. Esposito E, Cortesi R, Drechsler M, Paccamiccio L, Mariani P, et al. (2005) Cubosome Dispersions as Delivery Systems for Percutaneous Administration of Indomethacin. Pharml Res 22: 2163-2173. (Pubitemid 41821596)
15. Kwon T, Lee H, Kim J, Shin W, Park S, et al. (2010) In vitro skin permeation of cubosomes containing water soluble extracts of Korean barberry. Colloid Journal 72: 205-210.
16. Banks SL, Pinninti RR, Gill HS, Paudel KS, Crooks PA, et al. (2010) Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs. J Pharm Sci 99: 3072-3080.
17. Coulman SA, Barrow D, Anstey A, Gateley C, Morrissey A, et al. (2006) Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. Current Drug Delivery 3: 65-75.
18. Pearton M, Kang SM, Song JM, Kim YC, Quan FS, et al. (2010) Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine 28: 6104-6113.
19. Song JM, Kim YC, Lipatov AS, Pearton M, Davis CT, et al. (2010) Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice. Clin Vaccine Immunol 17: 1381-1389.
20. Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK (2009) Microneedle- Based Vaccines Vaccines for Pandemic Influenza. Springer Berlin Heidelberg. 369-393.
21. Kaushik S, Hord AH, Denson DD, McAllister DV, Smitra S, et al. (2001) Lack of Pain Associated with Microfabricated Microneedles. Anesthesia & Analgesia 92: 502-504. (Pubitemid 32127644)
22. Birchall J, Clemo R, Anstey A, John D (2011) Microneedles in Clinical Practice-An Exploratory Study Into the Opinions of Healthcare Professionals and the Public. Pharm Res 28: 95-106.
23. Mikszta JA, Sullivan VJ, Dean C, Waterston AM, Alarcon JB, et al. (2005) Protective Immunization against Inhalational Anthrax: A Comparison of Minimally Invasive Delivery Platforms. J Infect Dis 191: 278-288. (Pubitemid 40096387)
24. Widera G, Johnson J, Kim L, Libiran L, Nyam K, et al. (2006) Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine 24: 1653-1664. (Pubitemid 43238242)
25. Mikszta JA, Dekker JP, Harvey NG, Dean CH, Brittingham JM, et al. (2006) Microneedle-Based Intradermal Delivery of the Anthrax Recombinant Protective Antigen Vaccine. Infect Immunity 74: 6806-6810. (Pubitemid 44913155)
26. Dean CH, Alarcon JB, Waterston AM, Draper K, Early R, et al. (2005) Cutaneous Delivery of a Live, Attenuated Chimeric Flavivirus Vaccines against Japanese Encephalitis (ChimeriVaxTM-JE) in Non-Human Primates. Human Vaccines 1: 106-111.
27. Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, et al. (2002) Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med 8: 415-419. (Pubitemid 34407039)
28. Matriano JA, Cormier M, Johnson J, Young WA, Buttery M, et al. (2002) Macroflux microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm Res 19: 63-70. (Pubitemid 34075108)
29. Cahalan MD, Parker I, Wei SH, Miller MJ (2002) Two-photon tissue imaging: seeing the immune system in a fresh light. Nat Rev Immunol 2: 872-880. (Pubitemid 37328709)
30. Masters B, So P (2001) Confocal microscopy and multi-photon excitation microscopy of human skin in vivo. Opt Express 8: 2-10.
31. Helmchen F, Denk W (2005) Deep tissue two-photon microscopy. Nat Meth 2: 932-940. (Pubitemid 43108729)
32. Hadjantonakis A-K, Dickinson ME, Fraser SE, Papaioannou VE (2003) Technicolour transgenics: imaging tools for functional genomics in the mouse. Nat Rev Genet 4: 613-625. (Pubitemid 36917503)
33. Gauderon R, Lukins PB, Sheppard CJR (2001) Optimization of secondharmonic generation microscopy. Micron 32: 691-700.
34. Murzina TV, Kolmychek IA, Maidykovski AI, Nikulin AA, Sychev FY, et al. (2008) Second- and third-harmonic generation and hyper-Rayleigh scattering in porous-silicon-based photonic microcavities. Opt Lett 33: 2581-2583.
35. Mohler W, Millard AC, Campagnola PJ (2003) Second harmonic generation imaging of endogenous structural proteins. Methods 29: 97-109. (Pubitemid 36259916)
36. Coulman SA, Birchall JC, Alex A, Pearton M, Hofer B, et al. (2011) In Vivo, In Situ Imaging of Microneedle Insertion into the Skin of Human Volunteers Using Optical Coherence Tomography. Pharm Res 28: 66-81.
37. Rizwan SB, Assmus D, Boehnke A, Hanley T, Boyd BJ, et al. (2011) Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. Eur J Pharm Biopharm 79: 15-22.
38. Rattanapak T, Birchall J, Young K, Ishii M, Meglinski I, et al. (2013) Transcutaneous immunization using microneedles and cubosomes: Mechanistic investigations using Optical Coherence Tomography and Two-Photon Microscopy. J Control Rel 172: 894-903.
39. Myschik J, McBurney WT, Hennessy T, Phipps-Green A, Rades T, et al. (2008) Immunostimulatory biodegradable implants containing the adjuvant Quil-A-Part II: In vivo evaluation. J Drug Target 16: 224-232. (Pubitemid 351460651)
40. Valladeau J, Saeland S (2005) Cutaneous dendritic cells. Sem Immunol 17: 273- 283.
41. Zinchuk V, Grossenbacher-Zinchuk O (2001) Quantitative Colocalization Analysis of Confocal Fluorescence Microscopy Images. Current Protocols in Cell Biology: John Wiley & Sons, Inc.
42. Shklovskaya E, Roediger B, Fazekas de St. Groth B (2008) Epidermal and Dermal Dendritic Cells Display Differential Activation and Migratory Behavior While Sharing the Ability to Stimulate CD4+ T Cell Proliferation In Vivo. J Immunol 181: 418-430.
43. Nagao K, Ginhoux F, Leitner WW, Motegi S-I, Bennett CL, et al. (2009) Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. PNAS USA 106: 3312-3317.
44. Hirschberg H, van Kuijk S, Loch J, Jiskoot W, Bouwstra J, et al. (2012) A combined approach of vesicle formulations and microneedle arrays for transcutaneous immunization against hepatitis B virus. Eur J Pharm Sci 46: 1-7.
45. Zaric M, Lyubomska O, Touzelet O, Poux C, Al-Zahrani S, et al. (2013) Skin Dendritic Cell Targeting via Microneedle Arrays Laden with Antigen Encapsulated Poly-D-L-Lactide-co-Glycolide Nanoparticles Induces Efficient Anti-Tumour and Anti-Viral Immune Responses. ACS Nano. 7: 2042-2055.
46. Sen D, Forrest L, Kepler TB, Parker I, Cahalan MD (2010) Selective and site-specific mobilization of dermal dendritic cells and Langerhans cells by Th1- and Th2-polarizing adjuvants. PNAS USA 107: 8334-8339.
47. Pearton M, Kang S-M, Song J-M, Anstey AV, Ivory M, et al. (2010) Changes in Human Langerhans Cells Following Intradermal Injection of Influenza Virus- Like Particle Vaccines. PLoS ONE DOI: 10.1371/journal.pone.0012410.
48. Kubo A, Nagao K, Yokouchi M, Sasaki H, Amagai M (2009) External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers. J Exp Med 206: 2937-2946.
49. Stoitzner P, Tripp CH, Eberhart A, Price KM, Jung JY, et al. (2006) Langerhans cells cross-present antigen derived from skin. PNAS USA 103: 7783-7788.
50. Li H, Willingham SB, Ting JP-Y, Re F (2008) Cutting Edge: Inflammasome Activation by Alum and Alum's Adjuvant Effect Are Mediated by NLRP3. J Immunol 181: 17-21.
51. Ryan EJ, Daly LM, Mills KHG (2001) Immunomodulators and delivery systems for vaccination by mucosal routes. Trends Biotechnol 19: 293-304. (Pubitemid 32635187)
52. Poltorak A, He X, Smirnova I, Liu M-Y, Huffel CV, et al. (1998) Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene. Science 282: 2085-2088. (Pubitemid 29001265)
53. Ulrich JT, Myers KR (1995) Monophosphoryl lipid A as an adjuvant. Past experiences and new directions. Pharm Biotechnol 6: 495-524.
54. Demento SL, Eisenbarth SC, Foellmer HG, Platt C, Caplan MJ, et al. (2009) Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine 27: 3013-3021.
55. Chen M, Wang H, Chen W, Meng G (2011) Regulation of adaptive immunity by the NLRP3 inflammasome. Int Immunopharmacol 11: 549-554.
56. Sharp FA, Ruane D, Claass B, Creagh E, Harris J, et al. (2009) Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. PNAS USA 106: 870-875.
57. Martin M, Michalek SM, Katz J (2003) Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A. Infect Immunity 71: 2498-2507. (Pubitemid 36519862)
58. Re F, Strominger JL (2001) Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells. J Biol Chem 276: 37692-37699.
59. Etchart N, Desmoulins P-O, Chemin K, Maliszewski C, Dubois B, et al. (2001) Dendritic Cells Recruitment and In Vivo Priming of CD8+ CTL Induced by a Single Topical or Transepithelial Immunization Via the Buccal Mucosa with Measles Virus Nucleoprotein. J Immunol 167: 384-391. (Pubitemid 32567803)
60. Mackay LK, Stock AT, Ma JZ, Jones CM, Kent SJ, et al. (2012) Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. PNAS USA 109: 7037-7042.
61. Clark RA, Chong B, Mirchandani N, Brinster NK, Yamanaka K-i, et al. (2006) The Vast Majority of CLA+ T Cells Are Resident in Normal Skin. J Immunol 176: 4431-4439. (Pubitemid 44264423)
62. Ratzinger G, Stoitzner P, Ebner S, Lutz MB, Layton GT, et al. (2002) Matrix Metalloproteinases 9 and 2 Are Necessary for the Migration of Langerhans Cells and Dermal Dendritic Cells from Human and Murine Skin. J Immunol 168: 4361-4371. (Pubitemid 34441336)
63. Bursch LS, Wang L, Igyarto B, Kissenpfennig A, Malissen B, et al. (2007) Identification of a novel population of Langerin+ dendritic cells. J Exp Med 204: 3147-3156.
64. Wester RC, Maibach HI (2001) In vivo methods for percutaneous absorption measurements (Reprinted from Percutaneous Adsorption, pg 215-228, 1999). J Toxicol-Cut Ocular Toxicol 20: 411-422.
65. Bronaugh RL, Stewart RF, Congdon ER (1982) Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol Applied Pharmacol 62: 481-488. (Pubitemid 12136695)
66. Shiozuka M, Wagatsuma A, Kawamoto T, Sasaki H, Shimada K, et al. (2010) Transdermal delivery of a readthrough-inducing drug: a new approach of gentamicin administration for the treatment of nonsense mutation-mediated disorders. J Biochem 147: 463-470.
67. Yu Z, Chung WG, Sloat BR, Lohr CV, Weiss R, et al. (2011) The extent of the uptake of plasmid into the skin determines the immune responses induced by a DNA vaccine applied topically onto the skin. J Pharm Pharmacol 63: 199-205.